Associated Papers
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.
Ganoza CA et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2025
The genetic landscape of frontotemporal lobar degeneration: investigation of a diagnostic cohort of 2747 probands.
Cogan G et al.
Brain : a Journal of Neurology, 2025
41240362 (PubMed )
Supplement: awaf423_supplementary_data.zip › brain-2025-01866-File011.xlsx › Supplementary_table_2
ANXA11 Mutations in the FTD Spectrum: A Novel Finding in a Patient With Semantic Variant Primary Progressive Aphasia.
Meng Y et al.
European Journal of Neurology, 2025
40345169 (PubMed )
Supplement: ENE-32-e70187-s001.docx
The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.
Ulugut Erkoyun H et al.
Journal of Alzheimer's Disease : Jad, 2021
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
Moore KM et al.
The Lancet. Neurology, 2020
31810826 (PubMed )
Supplement: NIHMS1067362-supplement-Supplement.pdf
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.
Yu CE et al.
Archives of Neurology, 2010
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease.
Carecchio M et al.
Journal of the Neurological Sciences, 2009
Novel progranulin mutation detected in 2 patients with FTLD.
Skoglund L et al.
Alzheimer Disease and Associated Disorders, 0
Select a paper to view details